Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.

Knoefel LF, Werle-Schneider G, Dally H, Müller PJ, Edler L, Bartsch H, Tuengerthal S, Heussel CP, Reinmuth N, Thomas M, Risch A.

J Thorac Oncol. 2011 Jan;6(1):183-9. doi: 10.1097/JTO.0b013e3181f8a20e.

2.

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.

Scherf DB, Dally H, Müller P, Werle-Schneider G, Jäger B, Edler L, Tuengerthal S, Fischer JR, Drings P, Bartsch H, Risch A.

Eur Respir J. 2010 Feb;35(2):381-90. doi: 10.1183/09031936.00125608. Epub 2009 Jul 30.

3.

Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.

Müller PJ, Dally H, Klappenecker CN, Edler L, Jäger B, Gerst M, Spiegelhalder B, Tuengerthal S, Fischer JR, Drings P, Bartsch H, Risch A.

Int J Cancer. 2009 Apr 1;124(7):1669-74. doi: 10.1002/ijc.23956.

4.

Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis.

Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H, Fong KM, Larsen JE, Le Marchand L, London SJ, Risch A, Spitz MR, Stucker I, Weinshenker B, Wu X, Yang P.

Genet Med. 2007 Feb;9(2):67-73. Review.

PMID:
17304047
5.

Genetic risk profiles for cancer susceptibility and therapy response.

Bartsch H, Dally H, Popanda O, Risch A, Schmezer P.

Recent Results Cancer Res. 2007;174:19-36. Review.

PMID:
17302182
6.

Genotype relationships in the CYP3A locus in Caucasians.

Dally H, Bartsch H, Jäger B, Edler L, Schmezer P, Spiegelhalder B, Dienemann H, Drings P, Kayser K, Schulz V, Risch A.

Cancer Lett. 2004 Apr 15;207(1):95-9.

PMID:
15050738
7.

The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.

Dally H, Edler L, Jäger B, Schmezer P, Spiegelhalder B, Dienemann H, Drings P, Schulz V, Kayser K, Bartsch H, Risch A.

Pharmacogenetics. 2003 Oct;13(10):607-18.

PMID:
14515059
9.

Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers.

Dally H, Gassner K, Jäger B, Schmezer P, Spiegelhalder B, Edler L, Drings P, Dienemann H, Schulz V, Kayser K, Bartsch H, Risch A.

Int J Cancer. 2002 Dec 10;102(5):530-5.

10.

The chromosome-based challenge assay using fluorescence in situ hybridization: a possible test for increased cancer susceptibility.

Oberheitmann B, Schäfer J, Dally H, Garms A, Frentzel-Beyme R, Hoffmann W.

Mutat Res. 1999 Jul 16;428(1-2):157-64.

PMID:
10517989
11.
12.
13.

Interaction of carcinogenic metal compounds with deoxyribonucleic acid repair processes.

Hartwig A, Schlepegrell R, Dally H, Hartmann M.

Ann Clin Lab Sci. 1996 Jan-Feb;26(1):31-8.

PMID:
8834358
14.

DISCUSSION ON HYPERPIESIS.

Dally H.

Proc R Soc Med. 1926;19(Gen Rep):40-2. No abstract available.

15.

DISCUSSION ON BLOOD-PRESSURE.

Dally H.

Proc R Soc Med. 1923;16(Balneol Climatol Sect):3-5. No abstract available.

16.

A Discussion on "The Diagnostic Value of the Röntgen Rays in Diseases of the Chest.".

Dally H.

Proc R Soc Med. 1908;1(Electro Ther Sect):45-6. No abstract available.

Supplemental Content

Support Center